Cargando…

Current advances in Hodgkin’s lymphoma

Hodgkin’s lymphoma is a highly treatable malignancy. It has high cure rates yet there are many patients who relapse or are refractory to treatment. Traditionally, treatment has been with conventional chemotherapy; however, the development of brentuximab vedotin and immune checkpoint inhibitors has r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vadakara, Joseph, Andrick, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450804/
https://www.ncbi.nlm.nih.gov/pubmed/30993260
http://dx.doi.org/10.1016/j.cdtm.2019.02.003